Has Pfizer's Bid for Warner Killed the Only Strategic M&A Alternative?
The last resistance to the wave of pharmaceutical megadeals has fallen. Pfizer Inc.'s hostile bid for Warner-Lambert Co., interrupting Warner's friendly merger with American Home Products Corp. effectively calls into question the only viable alternative to M&A; co-promotions.
You may also be interested in...
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.